Oncology News Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test Bethlehem, PA – May 14, 2024 – Saladax Biomedical, Inc. (Saladax) is pleased to announce…John BuckleyJune 5, 2024
Videos Determining Clozapine Response vs. Nonresponse Determining Clozapine Response vs. Nonresponse Recorded in July 2023 at Saladax’s first Virtual Product Theater…John BuckleyJuly 24, 2023
Psychiatry News Antipsychotic finger prick test shows drastic wait reduction Originally posted at Med-Tech, please view the article at this link. The new finger prick…John BuckleyNovember 8, 2022
Psychiatry News New blood test drastically cutting waiting times in South London South London and Maudsley NHS Foundation Trust have rolled out a new blood test that…John BuckleyNovember 4, 2022
Psychiatry News Point of care blood test cuts results wait from 10 days to six minutes ReStart and South London and Maudsley NHS Trust have joined forces to develop a new…John BuckleyNovember 2, 2022
Psychiatry NewsGeneral News The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Presented at the 2022 College of Psychiatric and Neurologic Pharmacists Annual Meeting This is an Educational Presentation On The Role Of Antipsychotic TDM In Clinical Decision Making…John BuckleyMay 12, 2022
Psychiatry News Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a…John BuckleyApril 5, 2022
Psychiatry News Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter…John BuckleyMarch 15, 2022
General News Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…John BuckleyMarch 15, 2022
General News CEO Sal Salamone Honored with International Award for his Work in the Life Sciences Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…John BuckleyNovember 30, 2021
General News Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…John BuckleyNovember 22, 2021
General News Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…John BuckleySeptember 27, 2021
Psychiatry News Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…John BuckleyFebruary 17, 2021
Psychiatry News Saladax Hires 8 to Address Demand for Schizophrenia Medication Test Saladax Biomedical, Inc., Ben Franklin TechVentures, Bethlehem, has expanded its staff with eight new employees in…John BuckleyOctober 13, 2020
Psychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…John BuckleyJuly 8, 2020
Psychiatry News HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…John BuckleyJune 27, 2020
Oncology News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…John BuckleyMay 4, 2020
Psychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…John BuckleyMay 1, 2020
Psychiatry News Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…John BuckleyOctober 24, 2019
Psychiatry News Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…John BuckleySeptember 5, 2019
Oncology News Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…John BuckleySeptember 19, 2018
Psychiatry News Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…John BuckleyJune 26, 2018
Psychiatry News Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…John BuckleyMarch 21, 2018
General NewsOncology News Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…John BuckleyOctober 14, 2017
Psychiatry News Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers Tests can lead to early identification of Alzheimer’s Disease Bethlehem, PA--(BUSINESS WIRE)--January 18, 2017-- Saladax…John BuckleyJanuary 18, 2017
General News Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…John BuckleyOctober 28, 2016
Oncology News Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…John BuckleyOctober 19, 2016
Oncology News Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting Large Study Confirms the Benefit to Patients of Advanced Dosing Method Saladax Biomedical, Inc. recently…John BuckleyJune 9, 2015
Oncology News Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…John BuckleyJune 8, 2015
Oncology News Personalized Chemotherapy Tests Cleared for Use in China Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…John BuckleyJuly 23, 2014
Psychiatry NewsGeneral News The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Presented at the 2022 College of Psychiatric and Neurologic Pharmacists Annual Meeting This is an Educational Presentation On The Role Of Antipsychotic TDM In Clinical Decision Making…John BuckleyMay 12, 2022
General News Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…John BuckleyMarch 15, 2022
General News CEO Sal Salamone Honored with International Award for his Work in the Life Sciences Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…John BuckleyNovember 30, 2021
General News Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…John BuckleyNovember 22, 2021
General News Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…John BuckleySeptember 27, 2021
General NewsOncology News Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…John BuckleyOctober 14, 2017
General News Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…John BuckleyOctober 28, 2016
Psychiatry News Antipsychotic finger prick test shows drastic wait reduction Originally posted at Med-Tech, please view the article at this link. The new finger prick…John BuckleyNovember 8, 2022
Psychiatry News New blood test drastically cutting waiting times in South London South London and Maudsley NHS Foundation Trust have rolled out a new blood test that…John BuckleyNovember 4, 2022
Psychiatry News Point of care blood test cuts results wait from 10 days to six minutes ReStart and South London and Maudsley NHS Trust have joined forces to develop a new…John BuckleyNovember 2, 2022
Psychiatry NewsGeneral News The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Presented at the 2022 College of Psychiatric and Neurologic Pharmacists Annual Meeting This is an Educational Presentation On The Role Of Antipsychotic TDM In Clinical Decision Making…John BuckleyMay 12, 2022
Psychiatry News Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a…John BuckleyApril 5, 2022
Psychiatry News Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter…John BuckleyMarch 15, 2022
Psychiatry News Saladax Biomedical Announces Health Canada Approval of Five MyCare™ Psychiatry Laboratory Diagnostic Assay BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the approval of five MyCare™…John BuckleyFebruary 17, 2021
Psychiatry News Saladax Hires 8 to Address Demand for Schizophrenia Medication Test Saladax Biomedical, Inc., Ben Franklin TechVentures, Bethlehem, has expanded its staff with eight new employees in…John BuckleyOctober 13, 2020
Psychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…John BuckleyJuly 8, 2020
Psychiatry News HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…John BuckleyJune 27, 2020
Psychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…John BuckleyMay 1, 2020
Psychiatry News Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…John BuckleyOctober 24, 2019
Psychiatry News Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…John BuckleySeptember 5, 2019
Psychiatry News Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…John BuckleyJune 26, 2018
Psychiatry News Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…John BuckleyMarch 21, 2018
Psychiatry News Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers Tests can lead to early identification of Alzheimer’s Disease Bethlehem, PA--(BUSINESS WIRE)--January 18, 2017-- Saladax…John BuckleyJanuary 18, 2017
Oncology News Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test Bethlehem, PA – May 14, 2024 – Saladax Biomedical, Inc. (Saladax) is pleased to announce…John BuckleyJune 5, 2024
Oncology News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…John BuckleyMay 4, 2020
Oncology News Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…John BuckleySeptember 19, 2018
General NewsOncology News Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…John BuckleyOctober 14, 2017
Oncology News Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…John BuckleyOctober 19, 2016
Oncology News Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting Large Study Confirms the Benefit to Patients of Advanced Dosing Method Saladax Biomedical, Inc. recently…John BuckleyJune 9, 2015
Oncology News Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…John BuckleyJune 8, 2015
Oncology News Personalized Chemotherapy Tests Cleared for Use in China Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…John BuckleyJuly 23, 2014